JOHNSON & JOHNSON

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net earnings $15.4b $16.5b $15.3b $15.1b $14.7b $20.9b $17.9b $14.1b $26.8b
Net Income (Loss) Attributable to Parent $1.3b $15.3b $15.1b $14.7b $20.9b $35.2b $14.1b $26.8b
Cash and cash equivalents from continuing operations, beginning of period $21.9b $24.1b $19.7b
Cash and cash equivalents from discontinued operations, beginning of period $0 $0 $0
Income taxes, inclusive of discontinued operations $2.9b $2.8b $4.6b $4.2b $4.6b $4.8b $5.2b $6.7b $6.5b
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $13.3b $14.1b $26.8b
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent $21.8b $0 $0
Net Income (Loss) Attributable to Noncontrolling Interest
Depreciation, Depletion and Amortization $5.6b $6.9b $7.0b $7.2b $7.4b $7.5b $7.3b $7.5b
Amortization of Intangible Assets $3.0b $4.4b $4.5b $4.7b $4.7b $4.5b $4.5b $4.6b
Depreciation and amortization of property and intangibles $3.7b $3.8b $6.9b $7.0b $7.2b $7.4b $7.0b $7.3b $7.5b
Deferred Income Tax Expense (Benefit) $2.4b ($1.0b) ($2.5b) ($1.1b) ($2.1b) ($4.2b) ($2.2b) $1.5b
Deferred tax provision ($270.0m) ($341.0m) ($1.0b) ($2.5b) ($1.1b) ($2.1b) ($1.7b) ($2.2b) $1.5b
Share-based Payment Arrangement, Noncash Expense $962.0m $978.0m $977.0m $1.0b $1.1b $1.2b $1.2b $1.4b
Share-based Payment Arrangement, Expense $962.0m $978.0m $977.0m $1.0b $1.1b $1.1b $1.2b $1.4b
Gain (Loss) on Sale of Assets and Asset Impairment Charges $1.3b $1.2b $2.2b $111.0m $617.0m $117.0m $226.0m $263.0m
Gain (Loss) on Disposition of Assets $1.3b $1.2b
Income Tax Expense (Benefit) $16.4b $2.7b $2.2b $1.8b $1.9b $1.7b $2.6b $5.8b
Interest Expense Nonoperating $755.0m $971.0m
Other Nonoperating Income (Expense) ($183.0m) ($1.4b) ($2.5b) ($2.9b) ($489.0m) ($6.6b) ($4.7b) $7.2b
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable $633.0m $1.2b $289.0m ($774.0m) $2.4b $624.0m $406.0m $1.8b
Increase (Decrease) in Inventories ($581.0m) $644.0m $277.0m $265.0m $1.2b $1.3b $1.1b $1.4b
Equity Securities, FV-NI, Gain (Loss) ($400.0m) ($400.0m)
Foreign Currency Transaction Gain (Loss), before Tax ($216.0m) ($265.0m) ($267.0m) ($209.0m) ($236.0m) ($366.0m) ($214.0m) ($254.0m)
Gain (Loss) Related to Litigation Settlement $100.0m
Goodwill $31.9b $30.5b $33.6b $36.4b $35.2b $36.6b $44.2b $48.8b
Investment Income, Interest $385.0m $611.0m $357.0m $111.0m $53.0m $1.3b $1.3b $1.1b
Stock based compensation $874.0m $878.0m $978.0m $977.0m $1.0b $1.1b $1.1b $1.2b $1.4b
Asset write-downs $624.0m $283.0m $1.3b $1.1b $233.0m $989.0m $1.2b $405.0m $204.0m
Charges for acquired in-process research and development $483.0m $1.8b $109.0m
(Gain) on separation of Kenvue ($21.0b) $0 $0
Net gain on sale of assets/businesses ($2.6b) ($563.0m) ($1.2b) ($2.2b) ($111.0m) ($617.0m) ($380.0m) ($226.0m) ($263.0m)
Credit losses and accounts receivable allowances $18.0m ($11.0m) ($31.0m) ($20.0m) $63.0m ($48.0m) ($17.0m) $11.0m ($1.0m)
Increase in accounts receivable ($433.0m) ($1.1b) ($1.2b) ($289.0m) $774.0m ($2.4b) ($1.3b) ($406.0m) ($1.8b)
Increase in inventories ($449.0m) ($249.0m) ($644.0m) ($277.0m) ($265.0m) ($1.2b) ($2.5b) ($1.1b) ($1.4b)
Increase in accounts payable and accrued liabilities ($3.0m) $656.0m $4.0b $4.1b $5.1b $2.4b $1.1b $1.6b $2.4b
(Increase)/Decrease in other current and non-current assets $65.0m $18.0m ($275.0m) ($1.1b) ($3.7b) ($2.0b) $687.0m $1.7b ($6.2b)
(Decrease)/Increase in other current and non-current liabilities $2.2b ($1.1b) ($1.8b) $1.4b $744.0m ($1.1b) ($2.0b) $33.0m ($5.7b)
Proceeds from the disposal of assets/businesses, net $3.5b $1.3b $3.2b $3.3b $305.0m $711.0m $543.0m $675.0m $720.0m
Acquisitions, net of cash acquired ($954.0m) ($4.5b) ($899.0m) ($5.8b) ($7.3b) ($60.0m) ($17.7b) ($15.1b) ($17.5b)
Acquired in-process research and development/related milestones (Note 18) ($470.0m) ($1.8b) ($385.0m)
Credit support agreements activity, net $25.0m $100.0m ($333.0m) $281.0m ($28.0m) $272.0m ($226.0m)
Other (including capitalized licenses and milestones) ($57.0m) ($15.0m) ($148.0m) $575.0m ($294.0m) $114.0m $93.0m ($38.0m) ($34.0m)
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net $1.3b $1.2b $949.0m $954.0m $1.1b $1.0b $1.3b $838.0m $3.4b
Settlement of convertible debt acquired from Shockwave $0 ($970.0m) $0
Proceeds from Kenvue initial public offering $4.2b $0 $0
Cash transferred to Kenvue at separation ($1.1b) $0 $0
Interest $617.0m $730.0m $1.0b $995.0m $904.0m $990.0m $982.0m $2.0b $2.0b
Interest, net of amount capitalized $515.0m $628.0m $963.0m $925.0m $841.0m $941.0m $933.0m $1.9b $1.9b
Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards $1.2b $2.0b $2.1b $1.7b $1.9b $1.8b $2.1b $1.6b $2.6b
Discontinued Operation, Gain (Loss) on Disposal of Discontinued Operation, Net of Tax $21.0b $0 $0
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax ($359.0m) $192.0m ($7.0m) $53.0m
Net Cash Provided by (Used in) Operating Activities $19.3b $21.1b $22.2b $23.4b $23.5b $23.4b $23.4b $22.8b $24.3b $24.5b
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment ($3.5b) $3.3b $3.7b $3.5b $3.3b $3.7b ($3.7b) $4.5b $4.4b $4.8b
Payments to Acquire Businesses, Net of Cash Acquired $35.2b $899.0m $5.8b $7.3b $60.0m $0 $15.1b $17.5b
Payments to Acquire Investments $6.2b $5.6b $3.9b $21.1b $30.4b $10.9b $1.7b $920.0m
Purchases of investments ($40.8b) ($34.0b) ($5.6b) ($3.9b) ($21.1b) ($30.4b) ($32.4b) ($1.7b) ($920.0m)
Sales of investments $34.1b $35.8b $4.3b $3.4b $12.1b $25.0b $41.6b $2.5b $1.7b
Payments for (Proceeds from) Other Investing Activities $234.0m $464.0m ($44.0m) $521.0m $508.0m ($12.0m) $174.0m $162.0m
Net cash (used by)/from investing activities ($7.7b) ($4.8b) ($3.2b) ($6.2b) ($20.8b) ($8.7b) ($12.4b) ($18.6b) ($23.6b)
Net Cash Provided by (Used in) Investing Activities ($14.9b) ($3.2b) ($6.2b) ($20.8b) ($8.7b) $878.0m ($18.6b) ($23.6b)
Cash flows from financing activities:
Proceeds from Issuance of Long-term Debt $9.0b $5.0m $3.0m $7.4b $5.0m $0 $6.7b $9.1b
Proceeds from short-term debt $2.4b $111.0m $80.0m $39.0m $3.4b $2.0b $16.1b $15.3b $14.6b
Proceeds from long-term debt, net of issuance costs $75.0m $12.0b $5.0m $3.0m $7.4b $5.0m $2.0m $6.7b $9.1b
Proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to Kenvue at separation $8.0b $0 $0
Repayments of Long-term Debt $1.8b $1.6b $2.8b $1.1b $1.8b $1.6b $1.5b $1.8b
Repayment of short-term debt ($1.0b) ($2.0b) ($2.5b) ($100.0m) ($2.7b) ($1.2b) ($6.5b) ($9.5b) ($12.3b)
Repayment of long-term debt ($68.0m) ($2.2b) ($1.6b) ($2.8b) ($1.1b) ($1.8b) ($2.1b) ($1.5b) ($1.8b)
Payments for Repurchase of Common Stock $6.4b $5.9b $6.7b $3.2b $3.5b $5.1b $2.4b $6.0b
Repurchase of common stock ($5.3b) ($9.0b) ($5.9b) ($6.7b) ($3.2b) ($3.5b) ($6.0b) ($2.4b) ($6.0b)
Dividends to shareholders ($8.2b) ($8.6b) ($9.5b) ($9.9b) ($10.5b) ($11.0b) ($11.7b) ($11.8b) ($12.4b)
Proceeds from (Payments for) Other Financing Activities ($188.0m) ($148.0m) $575.0m ($294.0m) $114.0m ($269.0m) ($38.0m) ($34.0m)
Net cash used by financing activities ($10.8b) ($8.6b) ($18.5b) ($18.0b) ($6.1b) ($14.0b) ($8.9b) ($3.1b) ($5.5b)
Net Cash Provided by (Used in) Financing Activities ($7.7b) ($18.5b) ($18.0b) ($6.1b) ($14.0b) ($15.8b) ($3.1b) ($5.5b)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents ($9.0m) $89.0m ($178.0m) ($112.0m) ($289.0m) $201.0m
Effect of exchange rate changes on cash and cash equivalents ($1.5b) ($215.0m) ($241.0m) ($9.0m) $89.0m ($178.0m) ($312.0m) ($289.0m) $201.0m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($802.0m) ($3.3b) $502.0m $7.7b $2.2b ($4.4b)
(Decrease)/Increase in cash and cash equivalents ($791.0m) ($1.1b) $283.0m ($802.0m) ($3.3b) $502.0m ($360.0m) $2.2b ($4.4b)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $17.3b $14.0b $14.5b $21.9b $24.1b $19.7b
Cash, Cash Equivalents, and Short-term Investments
Cash and cash equivalents, beginning of year $14.5b $13.7b $17.8b $17.3b $14.0b $14.5b $14.1b $24.1b $19.7b
Supplemental disclosure of cash flow information:
Interest Paid, Excluding Capitalized Interest, Operating Activities $866.0m $963.0m $925.0m $841.0m $941.0m $1.8b $1.9b $1.9b
Income Taxes Paid, Net $6.5b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.